{"name": "PROLOR Biotech",
 "permalink": "prolor-biotech",
 "crunchbase_url": "http://www.crunchbase.com/company/prolor-biotech",
 "homepage_url": "http://www.prolor-biotech.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@prolor-biotech.com",
 "phone_number": "866-644-7811 ",
 "description": "",
 "created_at": "Fri Apr 26 05:18:22 UTC 2013",
 "updated_at": "Fri Apr 26 05:31:21 UTC 2013",
 "overview": "\u003Cp\u003EPROLOR Biotech is developing proprietary versions of already-approved therapeutic proteins. The Company\u2019s Carboxyl Terminal Peptide technology can be attached to an array of existing therapeutic proteins, stabilizing the therapy in the bloodstream and extending its lifespan without additional toxicity or loss of desired biological activity.\u003C/p\u003E\n\n\u003Cp\u003EPROLOR products under development include Human Growth Hormone (\u201chGH\u201d) for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone (a $3 billion market opportunity). PROLOR\u2019s hGH could potentially be injected once a week or twice per month instead of daily. PROLOR\u2019s hGH is scheduled for Phase III trials in 2013.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       80],
      "assets/images/resized/0025/5161/255161v1-max-150x150.jpg"],
     [[246,
       132],
      "assets/images/resized/0025/5161/255161v1-max-250x250.jpg"],
     [[246,
       132],
      "assets/images/resized/0025/5161/255161v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://finance.yahoo.com/news/opko-health-acquire-prolor-biotech-060000541.html",
   "source_description": "OPKO Health To Acquire PROLOR Biotech",
   "acquired_year": 2013,
   "acquired_month": 4,
   "acquired_day": 24,
   "acquiring_company":
    {"name": "OPKO Health",
     "permalink": "opko-health",
     "image":
      {"available_sizes":
        [[[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-150x150.jpg"],
         [[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-250x250.jpg"],
         [[150,
           29],
          "assets/images/resized/0005/9178/59178v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "7 Golda Meir Street",
    "address2": "Weizmann Science Park",
    "zip_code": "74140",
    "city": "Nes Ziona",
    "state_code": null,
    "country_code": "ISR",
    "latitude": 31.9149383,
    "longitude": 34.8022696}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        120],
       "assets/images/resized/0025/5162/255162v1-max-150x150.jpg"],
      [[250,
        201],
       "assets/images/resized/0025/5162/255162v1-max-250x250.jpg"],
      [[450,
        362],
       "assets/images/resized/0025/5162/255162v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}